Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction



Status:Recruiting
Conditions:Other Indications
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 75
Updated:6/28/2018
Start Date:September 19, 2017
End Date:March 2019
Contact:Scott Wolf, MD
Email:scott@aerinmedical.com
Phone:650-434-3247

Use our guide to learn which trials are right for you!

A Prospective, Non-Randomized Study to Evaluate Treatment Outcome of Nasal Airway Obstruction Using the Aerin Medical Vivaer™ Stylus

This study evaluates subjective and objective measures of treatment outcome after using the
Aerin Medical Vivaer™ Stylus to treat nasal obstruction

This is a non-significant risk, prospective, non-randomized study to evaluate subjective and
objective measures of nasal obstruction both before and after treatment with the Vivaer
Stylus. The Stylus is used to deliver radiofrequency (RF) energy to the nasal valve area to
improve symptoms in those diagnosed with nasal airway obstruction.

Inclusion Criteria:

- Complaints of nasal obstruction for at least 1 year

- Failed maximum medical therapy (4-6 weeks of steroids)

- Nasal Obstruction Symptom Evaluation (NOSE) score of ≥ 60 at Baseline

- Nasal valve is a primary or significant contributor to the subject's nasal obstruction
as determined by the study investigator (based on clinical presentation, physical
examination, nasal endoscopy, etc.) and the subject has a positive response to any of
the following temporary measures (based on patient history or during office exam):

1. Use of external nasal dilator strips (e.g., Breathe Right Strips)

2. Q-Tip test (manual intranasal lateralization)

3. Use of nasal stents

4. Cottle Maneuver (manual lateral retraction of the cheek)

Exclusion Criteria:

- Prior surgical treatment of the nasal valve

- Rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal
procedures within the past three (3) months

- Severe and/or chronic sinusitis, recurrent sinusitis, or allergies leading to nasal
obstruction and currently requiring oral corticosteroid therapy

- Severe case of any of the following: septal deviation, turbinate hypertrophy, polyps,
or ptotic nose tip believed to be the primary contributor to the subject's nasal
obstruction symptoms and warranting surgical intervention

- Known or suspected allergies or contraindications to the anesthetic agents and/or
antibiotic medications to be used during the study procedure session

- Known or suspected to be pregnant, or is lactating

- Other medical conditions which in the opinion of the investigator could predispose the
subject to poor wound healing or increased surgical risk
We found this trial at
1
site
915 Olentangy River Road
Columbus, Ohio 43212
Phone: 614-366-6221
?
mi
from
Columbus, OH
Click here to add this to my saved trials